ISET 2026

Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study

04/09/2026

In this video, vascular surgeon Nicolas Mouawad, MD, MPH, MBA, from McLaren Bay Region in Bay City, Michigan, highlights key findings from his presentation at ISET 2026 about the AVENTUS trial. This pivotal Investigational Device Exemption trial evaluated the safety and efficacy of the Aventus thrombectomy system (Inquis Medical) for the treatment of pulmonary embolism (PE). Dr Mouawad discusses how emerging thrombectomy technologies combined with autologous blood reinfusion may reshape the treatment landscape for PE, focusing on clinical outcomes, procedural efficiency, and patient safety.

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Vascular Disease Management or HMP Global, their employees, and affiliates.

Related Content

Pulmonary Embolism

New STORM-PE Data Show Computer-Assisted Vacuum Thrombectomy With Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients

04/13/2026

“Together with the initial STORM PE results, which demonstrated faster reperfusion and improved right ventricular recovery, this 90-day data highlights significant patient centered benefits of CAVT in intermediate high risk PE,” said Robert...

“Together with the initial STORM...

04/13/2026

Cath Lab Digest

ISET 2026

Clot Management in the IVC: Matching the Device to the Disease

02/11/2026

William T. Kuo, MD

During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.

During a Wednesday afternoon...

02/11/2026

Vascular Disease Management

Pulmonary Embolism

Jupiter Endovascular Announces Completion of Enrollment in SPIRARE II Pivotal Trial

02/04/2026

The SPIRARE II pivotal clinical trial is evaluating the Vertex™ Pulmonary Embolectomy System in patients with acute, intermediate-risk pulmonary embolism (PE).

The SPIRARE II pivotal clinical...

02/04/2026

Cath Lab Digest

Cardiovascular Scientific Forum

AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance

02/03/2026

Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...

Physician-led Collaboration...

02/03/2026

Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Stroke

Upfront Diagnostics Launches LVOne Rapid Stroke Blood Test Following Receiving UKCA; First Deployment Begins With London Ambulance Service

05/05/2026

May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...

May 5, 2026 – Cambridge, UK –...

05/05/2026

Vascular Disease Management

Pulmonary embolism

Thrombolex Announces Enrollment of 100th Patient in RAPID-PE Clinical Study

05/01/2026

Landmark Milestone Reached in Single-Arm Study Evaluating the BASHIR® Endovascular System for Pulmonary Embolism Treatment New Britain, PA, April 30, 2026 — Thrombolex, Inc., a medical device company dedicated to advancing minimally...

Landmark Milestone Reached in...

05/01/2026

Vascular Disease Management

Drug-Eluting Balloons

Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan

04/30/2026

The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)

The SELUTION SFA Japan clinical...

04/30/2026

Cath Lab Digest

Below-Ankle Intervention

Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle

04/29/2026

Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.

Serration Remodeling Therapy...

04/29/2026

Vascular Disease Management

Sirolimus-coated Balloons

Concept Medical Announces Preliminary 3-Year Sirona Data at Charing Cross Symposium 2026

04/28/2026

Preliminary 3-Year SIRONA Data Presented at CX-2026 Demonstrate Durable Freedom from Reintervention with MagicTouch PTA in Femoropopliteal Disease London, 21 April 2026: Concept Medical Inc., today announced the presentation of preliminary...

Preliminary 3-Year SIRONA Data...

04/28/2026

Vascular Disease Management

Bioresorbable Scaffolds

REVA Medical Announces Positive MOTIV BTK Trial Results Showing Superiority in Critical Limb-Threatening Ischemia Patients

04/23/2026

The MOTIV BTK trial met both its primary safety and efficacy endpoints, demonstrating that the MOTIV scaffold provides a statistically significant improvement in clinical outcomes compared to the current standard of care, balloon angioplasty.

The MOTIV BTK trial met both its...

04/23/2026

Cath Lab Digest

BTK Intervention

Abbott Unveils Post-Approval Study Data Demonstrating Potential of Esprit BTK to Treat Significantly Sicker Patients with CLTI and Complex Lesions

04/21/2026

Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...

Initial data from the...

04/21/2026

Cath Lab Digest

Chronic Venous Disease

InVera Medical Reports 12-Month Results From Pilot Trial of InVera Infusion Device Showing Vein Closure in 90% of Patients, Statistically Significant Quality of Life Improvements, and Excellent Safety

04/21/2026

Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation

Novel Non-Thermal Procedure for...

04/21/2026

Vascular Disease Management

Femoropopliteal Disease

Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease

04/21/2026

LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...

LOS ALTOS, Calif....

04/21/2026

Cath Lab Digest

Arteriovenous Fistula

Medtronic Reports Strong 12-Month Real-World Outcomes for IN.PACT™ AV Drug-Coated Balloon†

04/16/2026

Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population1 Medtronic, a global leader in healthcare technology, today announced...

Post-approval study’s primary...

04/16/2026

Vascular Disease Management

Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Vascular Disease Management or HMP Global, their employees, and affiliates.

Stay in the Know

News

HMP Global Products

Events